Clinical Trials in Baltimore

Showing 10121-10140 of 17,842 trials

ARMOR1: Study of TOK-001 to Treat Castration Resistant Prostate Cancer

NCT00959959

The purpose of this study is to determine whether TOK-001 is safe and shows biological effect in the treatment of castration resistant prostate cancer (CRPC).

Prostate Cancer

LTN PHARMACEUTICALS, INC.49 participantsStarted Oct 2009

Los Angeles, California, United States • San Bernardino, California, United States • Baltimore, Maryland, United States +5 more locations

TERMINATEDPhase 1/2< 1 mile

Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of HT-100 in Duchenne Muscular Dystrophy

NCT01847573

The main purpose of this study is to test the safety and tolerability of different, increasing doses of an experimental medication called HT-100 in boys and young men with Duchenne muscular dystrophy (DMD). The study medication, HT-100, is a medicine that may help promote healthy muscle regeneration, diminish inflammation and the resulting damage to muscle, and decrease the scar tissue that forms in the muscles of children with DMD. In this study, pharmacokinetic sampling, or measurements of the amount of HT-100 in the bloodstream will also be taken.

Duchenne Muscular Dystrophy

Processa Pharmaceuticals17 participantsStarted May 2013

Sacramento, California, United States • Baltimore, Maryland, United States • St Louis, Missouri, United States +2 more locations

ARMOR1: Study of TOK-001 to Treat Castration Resistant Prostate Cancer

Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of HT-100 in Duchenne Muscular Dystrophy

Find Trials by Condition in Baltimore

Open Label Extension Study of HT-100 in Patients With DMD

Study of Rapastinel as Monotherapy in Patients With MDD

Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients With Chronic Heart Failure

A Study of CK-2127107 in Patients With Spinal Muscular Atrophy

A Clinical Trial of KT07 Capsule in the U.S.A

Motivations, Expectations, and Decision-making of Sickle Cell Patients in Clinical Research

Home Therapy for Stroke Rehabilitation Using the HandSOME Exoskeleton

Study to Evaluate the Safety and Efficacy of CTP-656 in Patients With Cystic Fibrosis With CFTR Gating Mutations

A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea

AMG 827 in Subjects With Psoriatic Arthritis

Chemoradiation Therapy and Ipilimumab in Treating Patients With Stages IB2-IIB or IIIB-IVA Cervical Cancer

Pancreas Resection With and Without Drains

Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD

Safety and Efficacy of Pimavanserin in Adults With Parkinson's Disease and Depression

Bioequivalence of Generic Imiquimod Cream, 5% When Compared to Aldara™ (Imiquimod) Cream, 5% in the Treatment of Actinic Keratosis

A Phase 1, Open-label Trial of Oral Azacitidine (CC-486) Plus RCHOP in Subjects With Large B-Cell Lymphoma or Follicular Lymphoma or Transformed Lymphoma

A Personal Cancer Vaccine (NEO-PV-01) and APX005M or Ipilimumab With Nivolumab in Patients With Advanced Melanoma

An Efficacy and Safety Trial of Intravenous Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids